241 related articles for article (PubMed ID: 16511518)
21. Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients.
Romano G; Marino IR; Pentimalli F; Adamo V; Giordano A
Drug News Perspect; 2009 May; 22(4):185-96. PubMed ID: 19536363
[TBL] [Abstract][Full Text] [Related]
22. US panel advises resumption of gene trials.
Fox JL
Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
[No Abstract] [Full Text] [Related]
23. Medicine. Gene therapy--new challenges ahead.
Williams DA; Baum C
Science; 2003 Oct; 302(5644):400-1. PubMed ID: 14563994
[TBL] [Abstract][Full Text] [Related]
24. Bubble babies and bathwater.
Nat Biotechnol; 2002 Nov; 20(11):1063. PubMed ID: 12410236
[No Abstract] [Full Text] [Related]
25. Lentiviral vector integration sites in human NOD/SCID repopulating cells.
Laufs S; Guenechea G; Gonzalez-Murillo A; Zsuzsanna Nagy K; Luz Lozano M; del Val C; Jonnakuty S; Hotz-Wagenblatt A; Jens Zeller W; Bueren JA; Fruehauf S
J Gene Med; 2006 Oct; 8(10):1197-207. PubMed ID: 16960916
[TBL] [Abstract][Full Text] [Related]
26. Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13.
Ferber MJ; Eilers P; Schuuring E; Fenton JA; Fleuren GJ; Kenter G; Szuhai K; Smith DI; Raap AK; Brink AA
Cancer Genet Cytogenet; 2004 Oct; 154(1):1-9. PubMed ID: 15381365
[TBL] [Abstract][Full Text] [Related]
27. Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells.
Siapati EK; Bigger BW; Kashofer K; Themis M; Thrasher AJ; Bonnet D
Eur J Haematol; 2007 Apr; 78(4):303-13. PubMed ID: 17378892
[TBL] [Abstract][Full Text] [Related]
28. Enhancers are major targets for murine leukemia virus vector integration.
De Ravin SS; Su L; Theobald N; Choi U; Macpherson JL; Poidinger M; Symonds G; Pond SM; Ferris AL; Hughes SH; Malech HL; Wu X
J Virol; 2014 Apr; 88(8):4504-13. PubMed ID: 24501411
[TBL] [Abstract][Full Text] [Related]
29. Second cancer case halts gene-therapy trials.
Check E
Nature; 2003 Jan; 421(6921):305. PubMed ID: 12540867
[No Abstract] [Full Text] [Related]
30. QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis.
Appelt JU; Giordano FA; Ecker M; Roeder I; Grund N; Hotz-Wagenblatt A; Opelz G; Zeller WJ; Allgayer H; Fruehauf S; Laufs S
Gene Ther; 2009 Jul; 16(7):885-93. PubMed ID: 19387483
[TBL] [Abstract][Full Text] [Related]
31. Insertional mutagenesis and clonal dominance: biological and statistical considerations.
Fehse B; Roeder I
Gene Ther; 2008 Jan; 15(2):143-53. PubMed ID: 17972922
[TBL] [Abstract][Full Text] [Related]
32. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
33. Redefining the common insertion site.
Wu X; Luke BT; Burgess SM
Virology; 2006 Jan; 344(2):292-5. PubMed ID: 16271739
[TBL] [Abstract][Full Text] [Related]
34. Virology. Picking the right spot.
Trono D
Science; 2003 Jun; 300(5626):1670-1. PubMed ID: 12805525
[No Abstract] [Full Text] [Related]
35. The trials of gene therapy.
Nature; 2002 Nov; 420(6912):107. PubMed ID: 12432344
[No Abstract] [Full Text] [Related]
36. Risks and benefits of gene therapy.
Noguchi P
N Engl J Med; 2003 Jan; 348(3):193-4. PubMed ID: 12529458
[No Abstract] [Full Text] [Related]
37. Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line.
Matzner I; Savelyeva L; Schwab M
Cancer Lett; 2003 Jan; 189(2):207-19. PubMed ID: 12490314
[TBL] [Abstract][Full Text] [Related]
38. Gene therapy. What to do when clear success comes with an unclear risk?
Marshall E
Science; 2002 Oct; 298(5593):510-1. PubMed ID: 12386304
[No Abstract] [Full Text] [Related]
39. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.
Beard BC; Dickerson D; Beebe K; Gooch C; Fletcher J; Okbinoglu T; Miller DG; Jacobs MA; Kaul R; Kiem HP; Trobridge GD
Mol Ther; 2007 Jul; 15(7):1356-65. PubMed ID: 17440443
[TBL] [Abstract][Full Text] [Related]
40. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
